Cancer in Croatia; where do we stand and how to move forward?

Por Vrdoljak, Eduard
Publicado em 2012

Long-Lasting Partial Regression of Glioblastoma Multiforme Achieved by Edotecarin: Case Report

Por Vrdoljak, Eduard, Boban, Marijo, Saratlija-Novaković, Žana, Jović, Josipa
Publicado em 2006

Cancer epidemiology in Central and South Eastern European countries

Por Vrdoljak, Eduard, Wojtukiewicz, Marek Z, Pienkowski, Tadeusz, Bodoky, Gyorgy, Berzinec, Peter, Finek, Jindrich, Todorović, Vladimir, Borojević, Nenad, Croitoru, Adina
Publicado em 2011

Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Por Sparano, Joseph A., Vrdoljak, Eduard, Rixe, Oliver, Xu, Binghe, Manikhas, Alexey, Medina, Carlos, Ventilari Da Costa, Susanne Crocamo, Ro, Jungsil, Rubio, Gonzalo, Rondinon, Monica, Perez Manga, Gumersindo, Peck, Ronald, Poulart, Valerie, Conte, Pierfranco
Publicado em 2010

Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement

Por Vrdoljak, Eduard, Bodoky, Gyorgy, Jassem, Jacek, Popescu, Razvan A., Mardiak, Jozef, Pirker, Robert, Čufer, Tanja, Bešlija, Semir, Eniu, Alexandru, Todorović, Vladimir, Kubáčková, Kateřina, Kurteva, Galia, Tomašević, Zorica, Sallaku, Agim, Smichkoska, Snezhana, Bajić, Žarko, Šikić, Branimir I.
Publicado no Oncologist (2016)

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

Por Kim, Tae Won, Elme, Anneli, Kusic, Zvonko, Park, Joon Oh, Udrea, Anghel Adrian, Kim, Sun Young, Ahn, Joong Bae, Valencia, Ricardo Villalobos, Krishnan, Srinivasan, Bilic, Ante, Manojlovic, Nebojsa, Dong, Jun, Guan, Xuesong, Lofton-Day, Catherine, Jung, A Scott, Vrdoljak, Eduard
Publicado no Br J Cancer (2016)